Clinical Experience with Ethinyl Estradiol and D-Norgestrel as an Oral Contraceptive

Inman, 1968, Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of childbearing age, Br Med J, 2, 193, 10.1136/bmj.2.5599.193 Vessey, 1969, Investigation of relation between use of oral contraceptives and thromboembolic disease: a further report, Br Med J, 2, 631, 10.1136/bmj.2.5658.651 Sartwell, 1969, Thromboembolism and oral contraceptives: an epidemiologic case-control study, Am J Epidemiol, 90, 365, 10.1093/oxfordjournals.aje.a121082 Vessey, 1970, Postoperative thromboembolism and the use of oral contraceptives, Br Med J, 3, 123, 10.1136/bmj.3.5715.123 Greene, 1972, Oral contraceptive use in patients with thromboembolism following surgery, trauma or infection, Am J Public Health, 62, 680, 10.2105/AJPH.62.5.680 Sartwell, 1972, Oral contraceptives and thromboembolic disease, JAMA, 220, 416, 10.1001/jama.1972.03200030074024 Vessey, 1968, Venous thromboembolic disease and the use of oral contraceptives: a review of mortality statistics in England and Wales, Lancet, 2, 94, 10.1016/S0140-6736(68)90370-X Siegel, 1969, The association of mortality from thromboembolic disorders and oral contraceptive use, J Reprod Med Lying-In, 3, 44 Zimmerman, 1970, Pulmonary embolism and unexpected death in supposedly normal persons: a second look, N Engl J Med, 283, 1504, 10.1056/NEJM197012312832706 Drill, 1972, Oral contraceptives and thromboembolic disease, JAMA, 219, 583, 10.1001/jama.1972.03190310015004 Fuertes de la Haba, 1971, Thrombophlebitis among oral and non-oral contraceptive users, Obstet Gynecol, 38, 259 Kalman, 1969, Effects of oral contraceptives, Ann Rev Pharmacol, 9, 363, 10.1146/annurev.pa.09.040169.002051 Tietze, 1968, Statistical assessment of adverse experiences associated with the use of oral contraceptives, Clin Obstet Gynecol, 11, 698, 10.1097/00003081-196811030-00006 Inman, 1970, Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee on Safety of Drugs, Br Med J, 2, 203, 10.1136/bmj.2.5703.203 1970, Combined Oral Contraceptives: a statement by the Committee on Safety of Drugs, Br Med J, 2, 231, 10.1136/bmj.2.5703.231 Nelson, 1973, Selecting the optimum oral contraceptive, J Reprod Med, 11, 135 Goldzieher, 1971, A placebocontrolled double-blind cross-over investigation of the side effects attributed to oral contraceptives, Fertil Steril, 22, 609, 10.1016/S0015-0282(16)38469-2 Preston, 1972, A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives, Contraception, 6, 17, 10.1016/S0010-7824(72)80003-9 Bodin, 1972, Comparative efficacy and cycle control with low dose norgestrel/estrogen combination Rozenbaum, 1972, Preliminary results of a study on the combination: d-norgestrel 150 μg—ethinyl estradiol 30 μg Reis, 1973, Study with WL-20, a hormonal association of low estrogenic dozification, A Folha Medica, 67, 413 De Souza, 1973, Clinical studies with a new combination progestogen estrogen, WL-20, A Folha Medica, 67, 399 Pandolfi, 1973, Studies using a hormonal association with a low estrogenic dose, A Folha Medica, 67, 423 Bye, 1973, Clinical assessment of a low-estrogen combined oral contraceptive, Br Med J, 2, 389, 10.1136/bmj.2.5863.389 1973, Steroid contraceptives in the People’s Republic of China, N Eng J Med, 289, 533, 10.1056/NEJM197309062891012 Schneider, 1974, Inhibition of ovulation by means of a combined preparation with reduced amounts of active substance, Contraception, 9, 81, 10.1016/0010-7824(74)90096-1 Apelo, 1970, Results of a controlled study employing d-norgestrel and ethinyl estradiol. A new oral contraceptive combination, Contraception, 2, 391, 10.1016/S0010-7824(70)80002-6